GN Audio
GN.CO Large CapHealthcare · Medical Devices
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
GN Audio en bref
GN Audio (GN.CO) is currently trading at 88,56 € with a market capitalization of 11,3 Md €. The trailing P/E ratio stands at 49.2x, with a forward P/E of 16.27x. The 52-week range spans from 85,12 € to 125,90 €; the current price is 29.7% below the yearly high. Year-over-year revenue growth stands at -8.2%.
💰 Dividende
GN Audio currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
12 analystes évaluent GN Audio (GN.CO) au consensus : None. L'objectif de cours moyen est de 115,12 €, soit un potentiel de +29.99% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 80,65 € à 131,80 €.
GN Audio : la thèse d'investissement en détail
GN Audio (GN.CO) operates in the Healthcare — specifically Medical Devices — and is headquartered in Denmark. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario baissier
Revenue is contracting at -8.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.
À surveiller
- The forward P/E of 16.27x is meaningfully below the trailing 49.2x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 29.99% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 54.41% — signe d'un pouvoir de fixation des prix
- –CA en contraction (-8.2% sur un an)
- –Actuellement non rentable
- –Actuellement jugée surévaluée
- –Free cash flow négatif
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to market-like volatility.
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy GN Audio?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
